THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IS AN ACTIVE TRANSPLACENTAL CARCINOGEN IN SYRIAN GOLDEN-HAMSTERS

Authors:
  • PJPA JOSHI
    PA JOSHI
  • ACA CASTONGUAY
    A CASTONGUAY
  • HSHM SCHULLER
    HM SCHULLER
Google Scholar
  • 1 June 1990
    • journal article
    • research article
    • Vol. 50  (11) , 3435-3438
    • PMID:2334940
Abstract
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen in adult laboratory rodents. Our previous studies have shown that NNK crosses the placenta in pregnant hamsters and is metabolized into DNA-methylating and clastogenic intermediates by fetal respiratory tract tissues. Based on these findings, we have tested the transplacental carcinogenicity of NNK in this species. Groups of pregnant hamsters were given s.c. injections of single or multiple doses of NNK (cumulative dose range, 50-300 mg/kg) on day 15 (last day of gestation) or on days 13, 14, and 15 of gestation. Within 1 year after treatment, up to 70% of the offspring developed tumors in various organs, including respiratory tract, nasal cavity, adrenal glands, pancreas, and liver. No tumors were found in the control hamsters treated with the vehicle (trioctanoin) alone. The overall tumor incidence was proportional to the cumulative dose. Females had a generally higher tumor incidence than males.

This publication has 8 references indexed in Scilit: